Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × liposomal doxorubicin × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 16 Fallopian Tube Neoplasms 11 Breast Neoplasms 9 Triple Negative Breast Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Sarcoma 3 Sarcoma, Kaposi 2 Sarcoma, Ewing 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Neoplasm Metastasis 2 Multi-centric Castleman's Disease 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Acquired Immunodeficiency Syndrome 2 AIDS-related Kaposi sarcoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Vaccinia 1 Uterine Cervical Neoplasms 1 Rhabdomyosarcoma 1 Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Multiple Myeloma 1 Macular dystrophy, corneal type 1 1

Interventions

Carboplatin 36 Etoposide 34 durvalumab 29 atezolizumab 21 PM 01183 14 pembrolizumab 13 Topotecan 13 Cisplatin 13 Nivolumab 10 Paclitaxel 9 Drug Therapy 9 Specimen Handling 8 Platinum 8 Temozolomide 7 AMG 757 7 olaparib 6 anlotinib 6 Radiosurgery 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Docetaxel 6 berzosertib 5 Radiotherapy 5 Bevacizumab 5 trilaciclib 4 tremelimumab 4 Irinotecan 4 Biopsy 4 toripalimab 3 tislelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡